FindTrial
Sign In

palbociclib isethionate

DRUG2 trials

Sponsors

Pediatric Brain Tumor Consortium, M.D. Anderson Cancer Center

Conditions

Advanced Malignant Solid NeoplasmChildhood Choroid Plexus TumorChildhood EpendymoblastomaChildhood Grade III MeningiomaChildhood High-grade Cerebellar AstrocytomaChildhood High-grade Cerebral AstrocytomaChildhood MedulloepitheliomaMetastatic Malignant Solid Neoplasm

Phase 1

Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
TerminatedNCT02255461
Pediatric Brain Tumor ConsortiumChildhood Choroid Plexus Tumor, Childhood Ependymoblastoma, Childhood Grade III Meningioma +16
Start: 2014-12-08End: 2019-02-25Updated: 2021-03-02
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
RecruitingNCT04693468
M.D. Anderson Cancer CenterAdvanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm
Start: 2020-12-01End: 2027-12-31Target: 111Updated: 2026-03-13

Related Papers

Population Pharmacokinetic and Pharmacodynamic Study of Palbociclib in Children and Young Adults with Recurrent, Progressive, or Refractory Brain Tumors
Pharmaceutics2024-11-28